Impact
Our Roadmap
Pilot & Prove. Scale. National Influence. Three phases across three years, published openly so we can be held to them.
2027 – 2029
Strategic Growth & Impact Plan
Three phases, deliberately sequenced. Prove the model in one region. Scale what the evidence supports. Then work at national level. Select a phase to explore its objectives.
Pilot & Prove
January – December 2027
The year Stepin finds out whether the model works. Full-year delivery across education, outreach and early action, a patient navigation pilot, the first Women’s Cancer Summit — and, at the end of it, an impact report that says what actually happened.
Cancer education
Full-year delivery of Stepin Knowledge across communities, workplaces, schools and faith groups.
Community outreach
Sustained presence in target communities rather than one-off events.
Early-action campaigns
Themed monthly campaigns, from Know Your Risk in January to Stepin Impact in October.
Community Champions
Recruiting, training and supporting champions who carry education into their own neighbourhoods.
Referral pathways
Working referral routes agreed with clinical partners and tested in practice.
Patient navigation pilot
The core experiment of 2027: does navigation reduce drop-out between referral and assessment?
Women’s Cancer Summit
September 2027. Theme: From Awareness to Early Action.
Monitoring & evaluation
Data collected at every session and contact, analysed quarterly.
Impact reporting
Stepin’s first full public impact report, published December 2027.
Scale
2028
Growth guided by the 2027 evidence rather than by ambition. More communities, more champions, stronger navigation — and the funding base to sustain it without depending on any single source.
Expand communities
Extend beyond the 2027 pilot area within the Western Region.
More Community Champions
Grow the trained network, with supervision structures that scale with it.
Referral & navigation
Move navigation from pilot to standing service, based on what 2027 showed.
Expand research
Formal research collaborations with academic partners.
Digital programmes
Reaching women who cannot attend in person, and sustaining contact between sessions.
Corporate partnerships
Structured corporate partnership and sponsorship programme.
Institutional funding
Grant funding from institutional and international donors.
National Influence
2029
From a regional organisation with evidence to a national voice with standing. The aim is not for Stepin to become large, but for what Stepin has learned to change how cancer early detection works in Ghana.
Regional expansion
Extend beyond the Western Region where partnerships and capacity allow.
National influence
A recognised voice in Ghana’s women’s cancer conversation.
Advocacy
Evidence-based advocacy on screening access, referral speed and cancer service capacity.
Research
Published research on cancer awareness, early action and navigation in Ghana.
Health-system collaboration
Deeper structural collaboration with the Ghana Health Service and facilities.
Corporate partnerships
Long-term corporate relationships beyond single-campaign sponsorship.
Sustainability
A funding base diverse enough that no single withdrawal stops the work.
Why we publish this
An organisation that will not say where it is going cannot be held to it.
Most non-profits publish a mission and keep the plan internal. We have published the plan because partners, funders and the communities we work in are entitled to see what we said we would do — and to check, later, whether we did it.